Stock Track | STAAR Surgical Soars 14.32% in Pre-Market on Strong Q1 Earnings Beat and China-Led Recovery

Stock Track05-14

STAAR Surgical Company's stock surged 14.32% during pre-market trading on Thursday. The intraocular lens maker reported first-quarter financial results that significantly exceeded market expectations, driving a sharp rally in its shares.

The company swung to a profit with Q1 net income of $5.2 million, compared to a loss in the prior-year period. Revenue more than doubled year-over-year to a record $93.5 million, beating analyst estimates. Management attributed the strong performance to a recovery in demand in China, normalization of distributor inventory levels, and the successful launch of its EVO+ ICL product in the region.

Gross margin improved substantially to 73.6%, driven by manufacturing efficiencies. Following the earnings release, several analysts raised their price targets on the stock, reflecting increased confidence in the company's growth trajectory and its plan to supply the Chinese market from its Swiss facility to avoid import tariffs.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1199490957?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-14 15:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199490957","market":"hk","top_or_hot":-1,"title":"Stock Track | STAAR Surgical Soars 14.32% in Pre-Market on Strong Q1 Earnings Beat and China-Led Recovery","media":"Stock Track","content":"<p>STAAR Surgical Company's stock surged 14.32% during pre-market trading on Thursday. The intraocular lens maker reported first-quarter financial results that significantly exceeded market expectations, driving a sharp rally in its shares.</p><p>The company swung to a profit with Q1 net income of $5.2 million, compared to a loss in the prior-year period. Revenue more than doubled year-over-year to a record $93.5 million, beating analyst estimates. Management attributed the strong performance to a recovery in demand in China, normalization of distributor inventory levels, and the successful launch of its EVO+ ICL product in the region.</p><p>Gross margin improved substantially to 73.6%, driven by manufacturing efficiencies. Following the earnings release, several analysts raised their price targets on the stock, reflecting increased confidence in the company's growth trajectory and its plan to supply the Chinese market from its Swiss facility to avoid import tariffs.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | STAAR Surgical Soars 14.32% in Pre-Market on Strong Q1 Earnings Beat and China-Led Recovery</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | STAAR Surgical Soars 14.32% in Pre-Market on Strong Q1 Earnings Beat and China-Led Recovery\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-14 15:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>STAAR Surgical Company's stock surged 14.32% during pre-market trading on Thursday. The intraocular lens maker reported first-quarter financial results that significantly exceeded market expectations, driving a sharp rally in its shares.</p><p>The company swung to a profit with Q1 net income of $5.2 million, compared to a loss in the prior-year period. Revenue more than doubled year-over-year to a record $93.5 million, beating analyst estimates. Management attributed the strong performance to a recovery in demand in China, normalization of distributor inventory levels, and the successful launch of its EVO+ ICL product in the region.</p><p>Gross margin improved substantially to 73.6%, driven by manufacturing efficiencies. Following the earnings release, several analysts raised their price targets on the stock, reflecting increased confidence in the company's growth trajectory and its plan to supply the Chinese market from its Swiss facility to avoid import tariffs.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"STAA","symbol_name":"STAAR Surgical Company","start_time":0,"source_url":"","article_id":"1199490957","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199490957","pubTimestamp":1778744111,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"STAAR Surgical Company's stock surged 14.32% during pre-market trading on Thursday. The intraocular lens maker reported first-quarter financial results that significantly exceeded market...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"STAA":"STAAR Surgical Company"},"translate_title":"个股追踪|STAAR Surgical盘前飙升14.32%，因Q1盈利强劲超预期和中国引领的复苏","themeId":"a864cd6c65a287045b3e5b828572bce6","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STAA":1},"content_text":"STAAR Surgical Company's stock surged 14.32% during pre-market trading on Thursday. The intraocular lens maker reported first-quarter financial results that significantly exceeded market expectations, driving a sharp rally in its shares.The company swung to a profit with Q1 net income of $5.2 million, compared to a loss in the prior-year period. Revenue more than doubled year-over-year to a record $93.5 million, beating analyst estimates. Management attributed the strong performance to a recovery in demand in China, normalization of distributor inventory levels, and the successful launch of its EVO+ ICL product in the region.Gross margin improved substantially to 73.6%, driven by manufacturing efficiencies. Following the earnings release, several analysts raised their price targets on the stock, reflecting increased confidence in the company's growth trajectory and its plan to supply the Chinese market from its Swiss facility to avoid import tariffs.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1199490957","isCrawlerRequest":true}